Hints and tips:
Related Special Reports
...Along with striking a co-brand deal with CVS to offer Hyrimoz at a discounted price of $1,315 a month, Sandoz has a higher list price version of the biosimilar, priced similarly to Humira at more than $6,000...
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
US healthcare company is putting cash to work from spinning off its consumer health arm
UK trial shows ‘no difference’ between taking molnupiravir or placebo in reducing clinical admissions during Omicron wave
...The Swiss pharmaceuticals group is following many rivals to focus its operations on higher-value innovative treatments rather than the cheaper off-patent drugs made by Sandoz, including generic versions...
Millions of Paxlovid pills have gone unused as tight controls restrict access
...After raking in billions of dollars through sales of the Covid vaccine it co-developed with Germany’s BioNTech during the pandemic and seeing share prices surge, Pfizer has struggled to reorientate its pipeline...
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...Molnupiravir, marketed by Merck and co-developed with US biotech group Ridgeback Biotherapeutics, works by inducing small mutations in the virus itself....
...The reforms have been fiercely resisted by the pharmaceutical industry, which has warned they would cripple innovation and hinder development of life-saving medicines....
...The US government named 10 of the best-selling drugs as the first to face tough price regulations in a bid to slash healthcare costs, marking the biggest shake-up for the pharmaceutical industry in decades...
...Teixeira traded on the information and has pleaded guilty and agreed to co-operate with prosecutors....
...It was mostly sealed over an October dinner between Fink and GIP chair and co-founder Adebayo Ogunlesi at Fasano, an Italian restaurant near Rockefeller Center....
...In May, the Pharmaceutical Supply Chain Initiative, a lobby set up by large pharmaceutical companies, said its members should stop sourcing blood from the two Asian horseshoe crab species most at risk....
...The New Jersey pharmaceutical titan’s share price has doubled in the past five years, well ahead of the wider S&P 500 index....
...He said the acquisition may signal a shift in activity in the pharmaceutical sector towards more aggressive deployment of cash to scoop up biotech companies....
...Paul Killik is founder and senior executive officer, Killik & Co...
...It comes after decades during which many big pharmaceutical companies lost hope and cut investment in Alzheimer’s research....
...Grail’s early investors included Microsoft co-founder Bill Gates and Amazon’s Jeff Bezos....
US bankruptcy may be a tolerable, if imperfect, forum for resolving these cases
Proxy adviser says the two executives failed to take responsibility for destructive deal for Grail
...The US Food and Drug Administration in January approved lecanemab, a drug co-developed by Japanese drugmaker Eisai and US biotech Biogen, under an accelerated process....
...The FT’s US pharmaceutical correspondent Jamie Smyth helps us explore whether J&J’s use of this manoeuvre is setting a precedent for corporations to evade accountability in America....
Kenvue valued at $41bn after carve-out from US healthcare group
International Edition